FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

The Harvard Drug Group Omega-3-Acid Recall

Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose bliste…

The Harvard Drug Group LLC · Dublin, OH

Risk level
Class II
Reported by FDA
Apr 29, 2026
Recall ID
D-0493-2026
Check your lot numberHow we source this data

Summary

The Harvard Drug Group recalled Omega-3-Acid starting Apr 9, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0493-2026 on Apr 29, 2026. Reason: Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells. Status: Ongoing.

Why it was recalled

Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.

Product description

Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46288. NDC: 0904-7495-06

Lot numbers, UPCs & expiration codes

Lot#: Lot N02406, Exp 10/31/2026; Lot N02845, Exp 12/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0493-2026
Classification
Class II
Status
Ongoing
Recall initiated
Apr 9, 2026
FDA report date
Apr 29, 2026
Quantity
2,238 5 x 10 unit dose cartons
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group LLC

Original FDA data

Every field from FDA enforcement report D-0493-2026, exactly as published.

Show all FDA fields
City
Dublin
State
OH
Status
Ongoing
Country
United States
Event ID
98763
Address
7000 Cardinal Pl
Code information
Lot#: Lot N02406, Exp 10/31/2026; Lot N02845, Exp 12/31/2026
Postal code
43017-1091
Report date
Apr 29, 2026
Product type
Drugs
Recall number
D-0493-2026
Classification
Class II
Recalling firm
The Harvard Drug Group LLC
Product quantity
2,238 5 x 10 unit dose cartons
Reason for recall
Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46288. NDC: 0904-7495-06
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 9, 2026
Initial firm notification
Letter
Center classification date
Apr 24, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0493-2026, published Apr 29, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls